On one hand, they reported that atrial arrhythmia (atrial fibrillation/atrial flutter) is most common in patients with (L.)pathogenic variants affecting FBN1 compared to patients with (L.)pathogenic variants in other TGF-β signaling genes. This evidence concerns the gene FBN1 and atrial flutter.